Related references
Note: Only part of the references are listed.Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer A Population-Based Cohort Study
Farzin Khosrow-Khavar et al.
CIRCULATION (2020)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Cardiovascular Disease After Aromatase Inhibitor Use
Reina Haque et al.
JAMA ONCOLOGY (2016)
Share Paper
